Browsing Tag

Formulation/Drug Product Manufacturing

318 posts

Catalent Completes Biomfg Expansions; Aceto Acquires A&C
By

By
The latest from CDMOs, CMOs, and suppliers featuring Catalent, Lonza, Aceto, Abzena, and Ascendia Pharmaceuticals. Chemicals/Chemical API Manufacturing Aceto Acquires A&CAceto, a provider of specialty materials for life sciences and…

CDMO, CMO, Supplier Roundup in Supporting COVID-19 Projects
By

By
The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Catalent, Celonic, and Exothera. Biologics Manufacturing Celonic, CureVac in Mfg Pact for COVID-19 VaccineCelonic, a Basel, Switzerland-headquartered CDMO of advanced…

Fujifilm Breaks Ground for Facility Expansion; Sterling Acquires ADC Bio
By

By
The latest from CDMOs, CMOs, and suppliers featuring Fujifilm Diosynth Biotechnologies, Sterling Pharma Solutions, ADC Bio, Bora Pharmaceuticals, Crystec, and Cryoport. Biologics Manufacturing Fujifilm Diosynth Breaks Ground for Microbial Facility…

Resilience Expands Biologics Mfg with New Facilities
By

By
Resilience, a recently launched manufacturing and technology company for biologics and advanced therapies, has acquired two commercial manufacturing facilities in North America, including a facility from Sanofi. Resilence was launched…

NextPharma Acquires Lonza Sites; Catalent Divests BFS Sterile CDMO Biz
By

By
The latest from CDMOs, CMOs, and suppliers featuring Lonza, NextPharma, Catalent, Piramal Pharma Solutions, Asymchem, Aji Bio-Pharma, Rentschler Biopharma, and others. Chemicals/Chemical API Manufacturing Asymchem Expands Oligonucleotides Mfg Capacity Asymchem,…

Alcami Names New Chairman and CEO
By

By
The Board of Directors of Alcami, a CDMO of drug products and provider of analytical testing services, has appointed Patrick D. Walsh as Chairman and Chief Executive Officer (CEO), effective…

WuXi Biologics in Two Deals with Pfizer, CMAB Biopharma in China
By

By
WuXi Biologics, a contract biologics manufacturer, is increasing its position in China with two separate deals: an agreement to acquire Pfizer’s biologics drug-substance and drug-product manufacturing facilities in Hangzhou, China, and…

Vetter Opens Office in China; Arranta Bio, AGC Biologics Expand
By

By
The latest from CDMOs, CMOs, and suppliers featuring Arranta Bio, AGC Biologics, Vetter, Metrics Contract Services, CapsCanada, LabVantage, Univercells, and others. Biologics Manufacturing Arranta Bio To Add New $150 M-Mfg…

Fujifilm Diosynth, Cytiva, GRAM Expand; Pharmaron To Buy AbbVie Plant
By

By
The latest from CDMOs, CMOs, and suppliers featuring Fujifilm Diosynth, WuXi AppTec, Cytiva, Grand River Aseptic Manufacturing (GRAM), Stevanato Group, and others. Chemicals/Chemical API Manufacturing Phlow, USP Form Continuous Mfg…

Catalent Acquires Accorda’s Drug-Product, Pkg Ops; Lonza, Regis Expand
By

By
The latest from CDMOs, CMOs, and suppliers featuring Catalent, Lonza, Thermo Fisher, Fujifilm, Regis, Cascade Chemistry, Wavelength Pharmaceuticals, and others. Chemicals/Chemical API Manufacturing Regis Expands Facilities for API Development, Mfg…